OrbiMed’s Teleflex TFX Stock Holding History

OrbiMed’s Portfolio TFX Stock Details TFX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-157,300	Closed	-$41.9M	–	150
2018 Q3	$41.9M	Sell	157,300 -33,100	-17%	-$8.58M	0.5%	61
2018 Q2	$51.1M	Buy	190,400 +73,400	+63%	+$19.7M	0.61%	51
2018 Q1	$29.8M	Buy	+117,000	New	+$30.7M	0.37%	68

Other funds holding TFX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

OrbiMed's TFX Position: Q4 2018 in Review

OrbiMed sold out of Teleflex (TFX) in Q4 2018, closing a stake of 157,300 shares — an estimated $41.9M sold.

OrbiMed first reported a position in TFX in Q1 2018 and held it in 3 quarters. The position peaked at $51.1M in Q2 2018. 418 funds tracked by Wall St. Rank hold TFX as of Q4 2018.

OrbiMed reported no remaining Teleflex position as of Q4 2018 after selling out during the quarter.
OrbiMed sold 157,300 Teleflex shares in Q4 2018, an estimated $41.9M.
OrbiMed first reported a position in Teleflex in Q1 2018 and held it in 3 quarters.
OrbiMed's Teleflex position peaked at $51.1M in Q2 2018.
418 funds tracked by Wall St. Rank held Teleflex as of Q4 2018.

Based on OrbiMed's 13F filing for Q4 2018, filed 14 Feb 2019.